Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|December 5, 2020
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in miceSilvia Nitschke, Erin E Chown, Xiaochu Zhao, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 13, 2026
Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formationEsther O Alao, Mehrnaz Sheibani, Jun Wu, et al.
Acta Neuropathologica|February 27, 2024
Myofiber-type-dependent 'boulder' or 'multitudinous pebble' formations across distinct amylopectinosesSharmistha Mitra, Baozhi Chen, John M Shelton, et al.
EMBO Molecular Medicine|May 25, 2017
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora diseaseFelix Nitschke, Mitchell A Sullivan, Peixiang Wang, et al.
Carbohydrate Polymers|April 30, 2025
Covalently linked phosphate monoesters on alpha-polyglucans reduce substrate affinity of branching enzymesVictoria Butler, Hanan Shaaban, Lilya Nasanovsky, et al.
The EMBO Journal|January 13, 2025
Glycogen synthase GYS1 overactivation contributes to glycogen insolubility and malto-oligoglucan-associated neurodegenerative diseaseSilvia Nitschke, Alina P Montalbano, Megan E Whiting, et al.
Neurology. Genetics|October 27, 2025
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora DiseaseLorenzo Muccioli, Bazile Ganceviciute, Felicitas Becker, et al.
Communications Biology|May 20, 2024
GDE5/Gpcpd1 activity determines phosphatidylcholine composition in skeletal muscle and regulates contractile force in miceRahmawati Aisyah, Noriyasu Ohshima, Daiki Watanabe, et al.
Pageof 4